Company intelligence / Profile preview

DavosPharma

Upper Saddle River, New Jersey, United Statesdavos.com ↗

Ownership: Private
Employees: ~25
Development stage: Other

Overview

DavosPharma is a leading US-based CDMO/CRO providing integrated drug discovery, development, and custom cGMP manufacturing services for APIs (small molecules), NCEs, and biologics. With over 50 years of experience since 1972, the company has supported more than 80 IND filings and over 20 API/NCE launches for clients ranging from academic institutions to multinational pharma companies. Its global network of vetted partners enables end-to-end solutions including regulatory support.

Modalities: Small moleculeBiologicPeptidesProteinMonoclonal antibodyVaccine
Industry: Contract Research Organization

Partnerships

DavosPharma maintains strategic alliances with global cGMP manufacturers (CMOs/CDMOs) across the US, Europe, and Asia.It also partners with academic institutions such as Vanderbilt University Medical Center for early-stage studies

Beyond the preview

Go deeper on DavosPharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DavosPharma.

Explore the full profile